Search Results for "Mdvp Drug"

18:08 EST 25th November 2014 | BioPortfolio

Original Source: GHB and synthetic cathinones: clinical effects and potential consequences.

Designer drugs belong to a group of legally or illegally produced substances that are structurally and pharmacologically very similar to illicit drugs. In the past, designer drugs were often used during all-night dance parties, but they are now consumed in multiple settings from college bars to parks to private house parties. Most of these club drugs can be bought on legal websites and home-delivered for private parties. Recently, legal highs have once again become a burning media issue across the world. Ou...

Matching Channels

Matching News

Relationship between neighborhood drug sales, drug use found

A new study looks at neighborhood factors as a cause to explain illicit drug use, exploring the associations between the perceived frequency of drug sales, drug use, and peer attitudes towards drug us...

Gut Microbes and Medicines: How the GI environment impacts drug metabolism

A wide range of factors determines the safety and efficacy of a drug. For example, microorganisms in the gastrointestinal tract impact how a drug gets metabolized. Topics in this discussion includ...

NYU study finds relationship between neighborhood drug sales and drug use

(New York University) The study looks at neighborhood factors as a cause to explain illicit drug use, exploring the associations between the perceived frequency of drug sales, drug use, and peer attit...

EMA, FDA Grant Glioblastoma Drug Orphan Drug Designation

AbbVie announced the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have granted orphan drug designation to AbbVie's investigational compound ABT-414, an anti-epiderma...

Neurotrophic Keratitis Drug Gets Orphan Drug Designation

Dompe, a leader in R&D for new therapeutic solutions for the treatment of rare diseases, announced that rhNGF (Recombinant Human Nerve Growth Factor) has been designated as an orphan drug by the A...

FDA accepts first application for approval of a biosimilar drug, could decide in 10 months

The Food and Drug Administration is reviewing research data on what could become the first U.S.-approved "biosimilar" drug, a cheaper, sort-of generic version of a biologic drug.

Drug monitoring: Bright lights yield drug readout

Therapeutic drug monitoring is vital for maintaining drug concentrations within the body in real time, maximizing therapeutic effects while minimizing the risk of harmful overdosing or wasteful underd...

Eye drug wins first FDA approval for Omeros, shares rise

(Reuters) - Omeros Corp said the U.S. Food and Drug Administration had approved its drug for use in cataract and lens replacement surgeries, the first drug developed by the company to get marketing cl...

Matching PubMed Articles

Hair drug testing results and self-reported drug use among primary care patients with moderate-risk illicit drug use.

This study sought to examine the utility of hair testing as a research measure of drug use among individuals with moderate-risk drug use based on the internationally validated Alcohol, Smoking, and Su...

Compulsory drug detention and injection drug use cessation and relapse in Bangkok, Thailand.

Strategies to promote the reduction and cessation of injection drug use are central to human immunodeficiency virus prevention and treatment efforts globally. Though drug use cessation is a major focu...

Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties.

Drug-drug interactions (DDIs) are an important consideration in both drug development and clinical application, especially for co-administered medications. While it is necessary to identify all possib...

Pharmacokinetics of Lacosamide and Omeprazole Coadministration in Healthy Volunteers: Results from a Phase I, Randomized, Crossover Trial.

The antiepileptic drug lacosamide has a low potential for drug-drug interactions, but is a substrate and moderate inhibitor of the cytochrome P450 (CYP) enzyme CYP2C19.

Drug-induced lupus: Including anti-tumour necrosis factor and interferon induced.

Drug-induced lupus erythematosus is defined as a syndrome with clinical and serological features similar to systemic lupus erythematosus that is temporally related to continuous drug exposure and whic...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement